This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

9 Health Care Stocks With 100% Buy Ratings

6. Emergent BioSolutions (EBS - Get Report) is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies for use in preventing and treating disease. The company operates in two business segments: biodefense and commercial. The company will announce its first quarter results on May 5.

Net loss for the first quarter of 2011 is forecast at $12.8 million on sales of $24.8 million, compared to a net income of $2.5 million on $46.8 million sales recorded during 2010 first quarter, according to analysts polled by Bloomberg. Loss per share is pegged at 52 cents compared to earnings of 8 cents per share reported during the comparable quarter last year.

The company recently signed a modification to its current procurement contract with the U.S. government to supply an additional 3.42 million doses of BioThrax. The modification is valued at $101 million for the delivery and shipping of additional doses of BioThrax beginning third quarter of 2011.

All the six analysts covering the stock rate a buy on it. Analysts polled by Bloomberg expect the stock to gain around 34% over the next 12 months with a consensus target price of $31.5. The stock has gained 49% during the last one year and currently trades at a P/E of 15.1
4 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ALIM $4.63 0.43%
EBS $33.32 1.12%
HSTM $30.42 0.00%
ICUI $96.93 1.33%
OGXI $2.32 -0.43%

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs